ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY
https://doi.org/10.17749/2313-7347.2016.10.2.011-016
Abstract
About the Authors
A. V. Khromylev
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Khromylev Aleksei Viktorovich – graduate student of the Department of Obstetrics and Gynecology.
Address: ul. Trubetskaya, 8-2, Moscow, Russia, 119048.
A. D. Makatsariya
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Makatsariya Aleksandr Davidovich – MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medical and Preventive.
Address: ul. Trubetskaya, 8-2, Moskva, Russia, 119048.
References
1. Makatsariya A.D., Pshenichnikova E.B., Pshenichnikova T.B., Bitsadze V.O. Metabolic syndrome and thrombophilia in obstetrics and gynecology [Metabolicheskii sindrom i trombofiliya v akusherstve i ginekologii (in Russian)]. Moscow. 2006; 480 s.
2. Alessi M.C., Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thrombosis and Haemostasis. 2008; 99: 995-1000.
3. Badimon L., Hernandez Vera R., Vilahur G. Atherothrombotic risk in obesity. Hamostaseologie. 2013; 33: 259-68.
4. Bates S.M., Greer I.A., Pabinger I. et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 844-886.
5. Diamant M., Nieuwland R., Pablo R.F., Sturk A., Smit J.W., Radder J.K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation. 2002; 106: 2442-2447.
6. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259 (5091): 87-91.
7. Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006; 113: 1888-1904.
8. Kopp C.W., Kopp H.P., Steiner S. et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res. 2003; 11: 950-956.
9. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010; 314: 1-16.
10. Nieuwdorp M., Stroes E.S., Meijers J.C., Buller H. Hypercoagulability in the metabolic syndrome. Current Opinion in harmacology. 2005; 5: 155-159.
11. Robertson L., Wu O., Langhorne P. et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006; 132: 171-196.
12. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. Journal of Clinical Investigation. 2006; 116: 1793-180.
Review
For citations:
Khromylev A.V., Makatsariya A.D. ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY. Obstetrics, Gynecology and Reproduction. 2016;10(3):11-16. (In Russ.) https://doi.org/10.17749/2313-7347.2016.10.2.011-016
Views: 666
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
